全文获取类型
收费全文 | 308篇 |
免费 | 43篇 |
国内免费 | 3篇 |
专业分类
儿科学 | 9篇 |
妇产科学 | 4篇 |
基础医学 | 37篇 |
口腔科学 | 1篇 |
临床医学 | 64篇 |
内科学 | 95篇 |
皮肤病学 | 7篇 |
神经病学 | 16篇 |
特种医学 | 1篇 |
外科学 | 16篇 |
预防医学 | 34篇 |
眼科学 | 9篇 |
药学 | 40篇 |
肿瘤学 | 21篇 |
出版年
2022年 | 17篇 |
2021年 | 42篇 |
2020年 | 17篇 |
2019年 | 14篇 |
2018年 | 14篇 |
2017年 | 12篇 |
2016年 | 10篇 |
2015年 | 9篇 |
2014年 | 25篇 |
2013年 | 15篇 |
2012年 | 15篇 |
2011年 | 35篇 |
2010年 | 9篇 |
2009年 | 9篇 |
2008年 | 20篇 |
2007年 | 16篇 |
2006年 | 15篇 |
2005年 | 11篇 |
2004年 | 17篇 |
2003年 | 13篇 |
2002年 | 10篇 |
1998年 | 2篇 |
1997年 | 3篇 |
1996年 | 1篇 |
1994年 | 2篇 |
1933年 | 1篇 |
排序方式: 共有354条查询结果,搜索用时 15 毫秒
1.
Krzysztof Letachowicz Klaudia Bardowska Tomasz Krlicki Dorota Kamiska Mirosaw Banasik Karolina Zajdel Oktawia Mazanowska Katarzyna Madziarska Dariusz Janczak Magdalena Krajewska 《Renal failure》2021,43(1):113
BackgroundArteriovenous fistulae (AVFs) may remain patent after kidney transplantation (KTx), contributing to maladaptive cardiac remodeling. The flow in AVFs is associated with the diameter of its vessels and thus with the AVF location. The main objective of this study is to assess the influence of AVF location and its patency on the self-reported quality of life (QOL) of kidney transplant recipients (KTRs) with past history of hemodialysis.MethodsTo gain clinical data, during a scheduled visit, 353 KTRs were asked to fill out an anonymous questionnaire. From this group, 284 respondents were found eligible for analysis. The outcome was defined as prevalence of symptoms and health status, measured with the Left Ventricular Dysfunction-36 (LVD-36) Questionnaire in symptomatic patients.ResultsThe hemodialysis patients (n = 243) were divided into two groups according to AVF location, i.e., DAVF – distally located AVF – (n = 174) and PAVF – proximally located AVF – (n = 69). The proportion of patients with heart failure (HF) was higher in PAVF group (24% vs. 12%, p = 0.0482). In the multivariable regression, PAVF, serum creatinine levels, and the presence of HF or coronary artery disease (CAD) remained independent predictors of lower functional capacity. Among patients with heart disease, the presence of active AVF was independently associated with worse functional outcome (higher LVD-36 scores).ConclusionsThe influence of persistent PAVF in KTRs seems to be unfavorable, especially when coexisting with CAD or HF. Abbreviations: AVF arteriovenous fistula; BMI body mass index; CAD coronary artery disease; D-AVF distally-located arteriovenous fistula; EC exercise capacity; HD hemodialysis; HF heart failure; KTx kidney transplantation; KTR kidney transplant recipient; LVD-36 Left Ventricle Disfunction – 36; LVEF left ventricle ejection fraction; LVH left ventricle hypertrophy; NYHA New York Heart Association; P-AVF proximally located arteriovenous fistula; PD peritoneal dialysis; PRO patient-reported outcomes; QOL quality of life. 相似文献
2.
Gengrong Lin Glenn Pankuch Peter C. Appelbaum Klaudia Kosowska-Shick 《Antimicrobial agents and chemotherapy》2014,58(10):6251-6254
Oritavancin exhibited in vitro activity against 169 strains of vancomycin-susceptible, methicillin-resistant Staphylococcus aureus (MRSA) with MICs ranging from 0.03 to 1 μg/ml and against vancomycin-intermediate MRSA (VISA; n = 29), heterogeneous vancomycin-intermediate MRSA (hVISA; n = 5), and vancomycin-resistant MRSA (n = 5) strains, with MICs ranging from 0.12 to 4 μg/ml. For 10 MRSA isolates comprising 5 VISA and 5 hVISA strains, synergy between oritavancin and gentamicin, linezolid, or rifampin was observed against most of the strains tested using a time-kill method. 相似文献
3.
Lisa K. Ryan Katie B. Freeman Jorge A. Masso-Silva Klaudia Falkovsky Ashwag Aloyouny Kenneth Markowitz Amy G. Hise Mahnaz Fatahzadeh Richard W. Scott Gill Diamond 《Antimicrobial agents and chemotherapy》2014,58(7):3820-3827
There is a strong need for new broadly active antifungal agents for the treatment of oral candidiasis that not only are active against many species of Candida, including drug-resistant strains, but also evade microbial countermeasures which may lead to resistance. Host defense peptides (HDPs) can provide a foundation for the development of such agents. Toward this end, we have developed fully synthetic, small-molecule, nonpeptide mimetics of the HDPs that improve safety and other pharmaceutical properties. Here we describe the identification of several HDP mimetics that are broadly active against C. albicans and other species of Candida, rapidly fungicidal, and active against yeast and hyphal cultures and that exhibit low cytotoxicity for mammalian cells. Importantly, specificity for Candida over commensal bacteria was also evident, thereby minimizing potential damage to the endogenous microbiome which otherwise could favor fungal overgrowth. Three compounds were tested as topical agents in two different mouse models of oral candidiasis and were found to be highly active. Following single-dose administrations, total Candida burdens in tongues of infected animals were reduced up to three logs. These studies highlight the potential of HDP mimetics as a new tool in the antifungal arsenal for the treatment of oral candidiasis. 相似文献
4.
Klaudia Kwiatkowski Anna Piotrowska Ewelina Rojewska Wioletta Makuch Joanna Mika 《Journal of neuroimmune pharmacology》2017,12(3):402-419
Increasing evidence has indicated that activated glial cells releasing nociceptive factors, such as interleukins and chemokines, are of key importance for neuropathic pain. Significant changes in the production of nociceptive factors are associated with the low effectiveness of opioids in neuropathic pain. Recently, it has been suggested that CCL2/CCR2 signaling is important for nociception. Here, we studied the time course changes in the mRNA/protein level of CD40/Iba-1, CCL2 and CCR2 in the spinal cord/dorsal root ganglia (DRG) in rats following chronic constriction injury (CCI) of the sciatic nerve. Moreover, we examined the influence of intrathecal preemptive and repeated (daily for 7 days) administration of RS504393, CCR2 antagonist, on pain-related behavior and the associated biochemical changes of some nociceptive factors as well as its influence on opioid effectiveness. We observed simultaneous upregulation of Iba-1, CCL2, CCR2 in the spinal cord on 7th day after CCI. Additionally, we demonstrated that repeated administration of RS504393 not only attenuated tactile/thermal hypersensitivity but also enhanced the analgesic properties of morphine and buprenorphine under neuropathy. Our results proof that repeated administration of RS504393 reduced the mRNA and/or protein levels of pronociceptive factors, such as IL-1beta, IL-18, IL-6 and inducible nitric oxide synthase (iNOS), and some of their receptors in the spinal cord and/or DRG. Furthermore, RS504393 elevated the spinal protein level of antinociceptive IL-1alpha and IL-18 binding protein. Our data provide new evidence that CCR2 is a promising target for diminishing neuropathic pain and enhancing the opioid analgesic effects. 相似文献
5.
Jonathan A. Polonsky Joseph F. Wamala Hilde de Clerck Michel Van Herp Armand Sprecher Klaudia Porten Trevor Shoemaker 《The American journal of tropical medicine and hygiene》2014,90(5):790-793
Outbreaks of Ebola and Marburg virus diseases have recently increased in frequency in Uganda. This increase is probably caused by a combination of improved surveillance and laboratory capacity, increased contact between humans and the natural reservoir of the viruses, and fluctuations in viral load and prevalence within this reservoir. The roles of these proposed explanations must be investigated in order to guide appropriate responses to the changing epidemiological profile. Other African settings in which multiple filoviral outbreaks have occurred could also benefit from such information. 相似文献
6.
Klaudia Grądzka Kamila Kruczkowska-Tarantowicz Marzenna B. Klimiuk Janusz Kłoczko 《Acta haematologica Polonica》2013,44(3):340-343
Hairy cell leukemia (HCL) is a rare, chronic lymphoproliferative disorder. Currently, purine nucleoside analogs (PNA) constitute the first line treatment of HCL. Cladribine could induce long lasting remission in majority of patients with only a single cycle of therapy. In fact the relapsed patients could be treated successfully with cladribine too. Sometimes we observe the resistance to PNA. Rituximab and chemoimmunotherapy (rituximab plus cladribine) are effective in treatment of refractory HCL.We present a case of a 64-year-old man who was treated with rituximab after second progression of HCL. In March 2011, rituximab was given at a dose of 375 mg/m2 i.v. once a week for eight weeks, with result of achievement of PR. During the last hospitalization in March 2013 the persistence of PR was confirmed. 相似文献
7.
8.
9.
Multistep resistance selection and postantibiotic-effect studies of the antipneumococcal activity of LBM415 compared to other agents 总被引:1,自引:0,他引:1
下载免费PDF全文
![点击此处可从《Antimicrobial agents and chemotherapy》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Kosowska-Shick K Credito KL Pankuch GA DeWasse B McGhee P Appelbaum PC 《Antimicrobial agents and chemotherapy》2007,51(2):770-773
LBM415 is a peptide deformylase inhibitor active against gram-positive bacterial species and some gram-negative species. In multiselection studies, LBM415 had low MICs against all Streptococcus pneumoniae strains tested, regardless of their genotype, and selected resistant clones after 14 to 50 days. MIC increases correlated with changes mostly in the 70GXGXAAXQ77 motif in peptide deformylase. The postantibiotic effect of LBM415 ranged from 0.3 to 1.4 h. 相似文献
10.
Fiona Sewell Kathryn Chapman Paul Baldrick David Brewster Alan Broadmeadow Paul Brown Leigh Ann Burns-Naas Janet Clarke Alex Constan Jessica Couch Oliver Czupalla Andy Danks Joseph DeGeorge Lolke de Haan Klaudia Hettinger Marilyn Hill Matthias Festag Abby Jacobs David Jacobson-Kram Stephan Kopytek Helga Lorenz Sophia Gry Moesgaard Emma Moore Markku Pasanen Rick Perry Ian Ragan Sally Robinson Petra M. Schmitt Brian Short Beatriz Silva Lima Diane Smith Sue Sparrow Yvette van Bekkum David Jones 《Regulatory toxicology and pharmacology : RTP》2014